Impact of Anti PD-1 Therapy in Children, Adolescents and Young Adults (CAYA) Melanoma Patients

Not yet recruitingOBSERVATIONAL
Enrollment

70

Participants

Timeline

Start Date

March 31, 2024

Primary Completion Date

November 30, 2024

Study Completion Date

November 30, 2024

Conditions
Early MelanomaAdvanced Melanoma
Trial Locations (13)

Unknown

Aix-Marseille Universite, Marseille

Institut Curie, Paris

Ospedale universitario della Charité, Berlin

German Cancer Research Center (Deutsches Krebsforschungszentrum (DKFZ), Heidelberg

University Children's Hospital Tuebingen, Tübingen

Universita Degli Studi Di Firenze, Florence

Fondazione Irccs Istituto Nazionale Dei Tumori, Milan

Universita Cattolica Del Sacro Cuore, Roma

Princess Máxima Center for Pediatric Oncology (Prinses Máxima Centrum voor kinderoncologie), Utrecht

Narodowy Instytut Onkologii Im. Marii Sklodowskiej-Curie Panstwowy Instytut Badawczy, Warsaw

Institut Catala D'Oncologia, Barcelona

Instituto de Investigaciones Biomédicas August Pi i Sunyer, Barcelona

Karolinska University Hospital, Stockholm

All Listed Sponsors
lead

Azienda Ospedaliera di Perugia

OTHER

NCT06281912 - Impact of Anti PD-1 Therapy in Children, Adolescents and Young Adults (CAYA) Melanoma Patients | Biotech Hunter | Biotech Hunter